Effects of potent neutralizing antibodies from convalescent plasma in patients hospitalized for severe SARS-CoV-2 infection
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Effects of potent neutralizing antibodies from convalescent plasma in patients hospitalized for severe SARS-CoV-2 infection
Authors
Keywords
-
Journal
Nature Communications
Volume 12, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-05-27
DOI
10.1038/s41467-021-23469-2
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Convalescent Plasma Antibody Levels and the Risk of Death from Covid-19
- (2021) Michael J. Joyner et al. NEW ENGLAND JOURNAL OF MEDICINE
- Duration and key determinants of infectious virus shedding in hospitalized patients with coronavirus disease-2019 (COVID-19)
- (2021) Jeroen J. A. van Kampen et al. Nature Communications
- One hundred years of Haematologica
- (2020) Paolo Mazzarello HAEMATOLOGICA
- Efficacy and safety of convalescent plasma for severe COVID-19 based on evidence in other severe respiratory viral infections: a systematic review and meta-analysis
- (2020) Niveditha Devasenapathy et al. CANADIAN MEDICAL ASSOCIATION JOURNAL
- Treatment With Convalescent Plasma for Critically Ill Patients With Severe Acute Respiratory Syndrome Coronavirus 2 Infection
- (2020) Bin Zhang et al. CHEST
- Treatment of 5 Critically Ill Patients With COVID-19 With Convalescent Plasma
- (2020) Chenguang Shen et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- The effect of age on mortality in patients with Covid-19: a metanalysis with 611,583 subjects
- (2020) Clara Bonanad et al. Journal of the American Medical Directors Association
- Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study
- (2020) Fei Zhou et al. LANCET
- Virological assessment of hospitalized patients with COVID-2019
- (2020) Roman Wölfel et al. NATURE
- Remdesivir for the Treatment of Covid-19 — Preliminary Report
- (2020) John H. Beigel et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effectiveness of convalescent plasma therapy in severe COVID-19 patients
- (2020) Kai Duan et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A human monoclonal antibody blocking SARS-CoV-2 infection
- (2020) Chunyan Wang et al. Nature Communications
- C-Reactive Protein Level May Predict the Risk of COVID-19 Aggravation
- (2020) Guyi Wang et al. Open Forum Infectious Diseases
- Gender Differences in Patients With COVID-19: Focus on Severity and Mortality
- (2020) Jian-Min Jin et al. Frontiers in Public Health
- Risk factors for 2019 novel coronavirus disease (COVID-19) patients progressing to critical illness: a systematic review and meta-analysis
- (2020) Lizhen Xu et al. Aging-US
- Lymphopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: A systemic review and meta-analysis
- (2020) Qianwen Zhao et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- Errors in Trial of Effect of Convalescent Plasma Therapy on Time to Clinical Improvement in Patients With Severe and Life-threatening COVID-19
- (2020) Zhong Liu JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Pooling Data From Individual Clinical Trials in the COVID-19 Era
- (2020) Eva Petkova et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections
- (2020) Quan-Xin Long et al. NATURE MEDICINE
- Dexamethasone in Hospitalized Patients with Covid-19 — Preliminary Report
- (2020) NEW ENGLAND JOURNAL OF MEDICINE
- Potent neutralizing antibodies from COVID-19 patients define multiple targets of vulnerability
- (2020) Philip J. M. Brouwer et al. SCIENCE
- An evaluation of COVID-19 serological assays informs future diagnostics and exposure assessment
- (2020) Corine H. GeurtsvanKessel et al. Nature Communications
- Convalescent Plasma for the Treatment of COVID-19: Perspectives of the National Institutes of Health COVID-19 Treatment Guidelines Panel
- (2020) Alice K. Pau et al. ANNALS OF INTERNAL MEDICINE
- Convalescent plasma treatment of severe COVID-19: a propensity score–matched control study
- (2020) Sean T. H. Liu et al. NATURE MEDICINE
- Convalescent plasma in the management of moderate covid-19 in adults in India: open label phase II multicentre randomised controlled trial (PLACID Trial)
- (2020) Anup Agarwal et al. BMJ-British Medical Journal
- Repurposed Antiviral Drugs for Covid-19 — Interim WHO Solidarity Trial Results
- (2020) NEW ENGLAND JOURNAL OF MEDICINE
- Neutralizing antibodies for the treatment of COVID-19
- (2020) Shibo Jiang et al. Nature Biomedical Engineering
- Prevention of hepatitis B virus infection: from the past to the future
- (2015) R. Orlando et al. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
- The Effectiveness of Convalescent Plasma and Hyperimmune Immunoglobulin for the Treatment of Severe Acute Respiratory Infections of Viral Etiology: A Systematic Review and Exploratory Meta-analysis
- (2014) John Mair-Jenkins et al. JOURNAL OF INFECTIOUS DISEASES
- Hyperimmune IV Immunoglobulin Treatment
- (2013) Ivan F.N. Hung et al. CHEST
- Passive immunity in the prevention of rabies
- (2012) Leonard Both et al. LANCET INFECTIOUS DISEASES
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started